 DARTMOUTH, Nova Scotia CAMBRIDGE, Mass.--BUSINESS WIRE--IMV Inc. Nasdaq: IMV; TSX: IMV IMV or the Company, a clinical-stage company developing a portfolio of immune-educating cancer therapies based on its novel DPX platform, today announced that IMVs executive management team will be participating in the upcoming Piper Sandler Virtual Healthcare Conference. On-demand starting Tuesday, November 23, 2021 11:00 a.m. ET Format: Fireside chat Actual conference: November 30 - December 2, 